53 citations as recorded by crossref.

1. External Validation of the Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH) Classification for Predicting Outcome in Periprosthetic Joint Infections: A Cohort of 653 Patients N. Kristensen et al. 10.1016/j.arth.2024.03.070
2. Interleukin-1β Polymorphisms Are Genetic Markers of Susceptibility to Periprosthetic Joint Infection in Total Hip and Knee Arthroplasty V. Granata et al. 10.3390/genes15050596
3. Patient mortality after total hip arthroplasty revision surgery G. Jayasinghe et al. 10.1016/j.jor.2023.11.020
4. Delayed Diagnosis of Mycobacterium bovis bacillus Calmette-Guérin Periprosthetic Joint Infection Following Total Knee Arthroplasty C. Pelt et al. 10.1016/j.artd.2024.101350
5. Single-stage revision in the management of prosthetic joint infections after total knee arthroplasty – A review of current concepts T. Pradhan et al. 10.1016/j.jcot.2024.102431
6. Surfaces Containing Sharp Nanostructures Enhance Antibiotic Efficacy R. Bright et al. 10.1021/acs.nanolett.2c02182
7. High Mortality After Total Knee Arthroplasty Periprosthetic Joint Infection is Related to Preoperative Morbidity and the Disease Process but Not Treatment N. Drain et al. 10.1016/j.arth.2022.03.046
8. Early Periprosthetic Joint Infections in Total Hip and Knee Arthroplasty: Microorganisms, Mortality, and Implant Survival Using a Combined Dataset From the Dutch Arthroplasty Register and the Dutch National Nosocomial Surveillance Network M. van Veghel et al. 10.1016/j.arth.2024.07.019
9. Should All Patients Receive Extended Oral Antibiotic Prophylaxis? Defining Its Role in Patients Undergoing Primary and Aseptic Revision Total Joint Arthroplasty K. Bundschuh et al. 10.1016/j.arth.2024.01.012
10. Trends in Extended Oral Antibiotic Prophylaxis Utilization Following Primary and Revision Total Hip Arthroplasty From 2010 to 2022 A. Zhao et al. 10.1016/j.arth.2024.01.016
11. The value of sonication on orthopaedic implants in an everyday clinical setting – an exploratory study D. Ponraj et al. 10.1186/s12891-023-06796-x
12. Intrawound Vancomycin Powder in Primary Total Hip Arthroplasty: A Prospective Quality Control Study S. Doxey et al. 10.1016/j.arth.2024.03.063
13. “Once more, with feeling”: no difference in outcomes between patients discharged on oral versus intravenous antibiotics for orthopedic infections in a propensity score matched cohort at a US medical center J. Gray et al. 10.1017/ash.2024.57
14. Staphylococcus epidermidis joint isolates: Whole-genome sequencing demonstrates evidence of hospital transmission and common antimicrobial resistance S. Simon et al. 10.1017/ice.2023.253
15. Are Patient-Reported Drug Allergies Associated With Prosthetic Joint Infections and Functional Outcomes Following Total Hip and Knee Arthroplasty? N. Fisher et al. 10.1016/j.arth.2021.09.008
16. Improve Integration of In Vitro Biofilm Body of Knowledge to Support Clinical Breakthroughs in Surgical Site Infection S. Irwin et al. 10.5435/JAAOSGlobal-D-20-00217
17. Modern Microbiological Methods to Detect Biofilm Formation in Orthopedy and Suggestions for Antibiotic Therapy, with Particular Emphasis on Prosthetic Joint Infection (PJI) P. Mikziński et al. 10.3390/microorganisms12061198
18. The CCJR® Charles A. Engh, Sr, MD. Excellence in Hip Research Award: The Evolution of Revision Hip Arthroplasty and Impact on the Trainee’s Experience S. Muscatelli et al. 10.1016/j.arth.2024.03.003
19. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis A. Anoushiravani et al. 10.1016/j.arth.2023.02.067
20. Outcomes of Debridement, Antibiotics, and Implant Retention in the Management of Infected Total Knee Arthroplasty: Analysis of 5,178 Cases From the National Australian Registry N. Kristensen et al. 10.1016/j.arth.2024.12.016
21. Increased short- and long-term mortality amongst patients with early periprosthetic knee joint infection O. Thompson et al. 10.1186/s12891-022-06024-y
22. Simultaneous Periprosthetic Joint Infection and Infective Endocarditis: Prevalence, Risk Factors, and Clinical Presentation M. Held et al. 10.1016/j.arth.2024.09.034
23. A novel strategy for eradication of staphylococcal biofilms using blood clots K. Grooters et al. 10.3389/fcimb.2025.1507486
24. Similar Efficacy and Lower Cost Associated With Ceftazidime Compared to Tobramycin Coupled With Vancomycin in Antibiotic Spacers in the Treatment of Periprosthetic Joint Infection D. Lewis et al. 10.1016/j.arth.2024.04.018
25. Insight into antibacterial effect of titanium nanotubular surfaces with focus on Staphylococcus aureus and Pseudomonas aeruginosa J. Šístková et al. 10.1038/s41598-024-68266-1
26. Mid-term follow-up results after implementing a new strategy for the diagnosis and management of periprosthetic joint infections R. Birlutiu et al. 10.1186/s12879-021-06407-x
27. Risk factors for mortality following one-stage septic hip arthroplasty — a case–control study S. Busch et al. 10.1007/s00264-021-05230-y
28. Biofilm and How It Relates to Prosthetic Joint Infection A. MacConnell et al. 10.1016/j.ocl.2023.10.001
29. Triaging Total Hip Arthroplasty During the COVID-19 Pandemic J. Rizkalla et al. 10.1007/s12178-020-09642-y
30. An in silico testbed for fast and accurate MR labeling of orthopedic implants G. Noetscher et al. 10.7554/eLife.90440
31. Middle-term two-stage treatment results of fistulous and non-fistulous form of chronic hip periprosthetic joint infection A. Kochish et al. 10.17816/vto633949
32. Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection Z. Van Roy et al. 10.1038/s41467-024-53353-8
33. Detailed Revision Risk Analysis after Single- vs. Two-Stage Revision Total Knee Arthroplasty in Periprosthetic Joint Infection: A Retrospective Tertiary Center Analysis L. Tuecking et al. 10.3390/antibiotics10101177
34. Approach to patients with a potential prosthetic joint infection B. Atkin et al. 10.1136/bmj-2021-069502
35. An in silico testbed for fast and accurate MR labeling of orthopedic implants G. Noetscher et al. 10.7554/eLife.90440.3
36. Molecular sequencing technologies in the diagnosis and management of prosthetic joint infections Z. Gamie et al. 10.1080/14737159.2021.1894929
37. The AAHKS Clinical Research Award: Extended Oral Antibiotics Prevent Periprosthetic Joint Infection in High-Risk Cases: 3855 Patients With 1-Year Follow-Up M. Kheir et al. 10.1016/j.arth.2021.01.051
38. The Investigation and Management of Peri-Prosthetic Joint Infection After Total Knee Arthroplasty: An Update Based on the Latest British Orthopaedic Association Standard and Speciality Standard Guidelines S. Doski et al. 10.7759/cureus.73315
39. Prevention of Prosthetic Joint Infection: From Traditional Approaches towards Quality Improvement and Data Mining J. Gallo & E. Nieslanikova 10.3390/jcm9072190
40. Acute kidney injury in the context of staged revision arthroplasty and the use of antibiotic-laden cement spacers: a systematic review Y. Chaudhry et al. 10.1186/s13018-023-03809-2
41. What are the risk factors and microorganism profiles of periprosthetic hip joint infections with a concomitant sinus tract? M. Budin et al. 10.1007/s00402-024-05713-8
42. Antibiotic Therapy for Prosthetic Joint Infections: An Overview B. Le Vavasseur & V. Zeller 10.3390/antibiotics11040486
43. Comparison of Five-Day vs. Fourteen-Day Incubation of Cultures for Diagnosis of Periprosthetic Joint Infection in Hip Arthroplasty C. Baez et al. 10.3390/jcm13154467
44. External Validation Demonstrates Limited Clinical Utility of a Preoperative Prognostic Calculator for Periprosthetic Joint Infection R. Monárrez et al. 10.1016/j.arth.2021.02.067
45. Prevalence and Factors Associated with Prosthetic Joint Infections in Patients with Staphylococcus aureus Bacteraemia: A 7-Year Retrospective Study M. Papadimitriou-Olivgeris et al. 10.3390/antibiotics11101323
46. Biofilms—What Should the Orthopedic Surgeon know? M. Dhillon et al. 10.1007/s43465-022-00782-6
47. Diagnosis of orthopaedic-implant-associated infections caused by slow-growing Gram-positive anaerobic bacteria – a clinical perspective D. Ponraj et al. 10.5194/jbji-6-367-2021
48. Assessment of sonication-based culture in diagnosing orthopedic implant infections: a comparative analysis with microbiological diagnostic approaches Y. ÇEKLİ & D. EGE 10.32322/jhsm.1361635
49. Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030 A. Schwartz et al. 10.1016/j.arth.2020.02.030
50. Risk Factors for Therapeutic Failure and One-Year Mortality in Patients with Intramedullary Nail-Associated Infection after Trochanteric and Subtrochanteric Hip Fracture Repair B. Pfang et al. 10.3390/antibiotics13050463
51. Does Treatment at a Specialized Prosthetic Joint Infection Center Improve the Rate of Reimplantation T. Fehring et al. 10.1016/j.arth.2023.03.082
52. Does Vancomycin Resistance Increase Mortality? Clinical Outcomes and Predictive Factors for Mortality in Patients with Enterococcus faecium Infections J. Hemapanpairoa et al. 10.3390/antibiotics10020105
53. Short-term outcomes of articular cement spacer in the treatment of prosthetic knee joint infections: a retrospective case series P. Yeo et al. 10.4103/singaporemedj.SMJ-2021-389